The Napp Pharmaceutical Group of companies is based in the UK, but we are part of a broader network of independently associated companies that have a presence in 33 countries across Europe, and others throughout the rest of the world, including the USA, China, India, Central and South America, Canada, Australia, the Middle East, Japan, Africa and South East Asia.
Our independently associated companies Mundipharma International limited (MINT) and Mundipharma Research Limited (MRL) are also based on the Science Park in Cambridge. MINT provides multidisciplinary support services for the independent associates based throughout Europe, including business development. MRL provides pre-clinical and clinical research and regulatory services.
Napp’s commercial activities are restricted to the UK, but our manufacturing facility supplies products to independent associates in 45 countries, enabling them to bring benefit to patients around the world.